Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;38(6-7):466-477.
doi: 10.1177/08830738231177386. Epub 2023 Jun 1.

Electroencephalographic (EEG) Biomarkers in Genetic Neurodevelopmental Disorders

Affiliations
Review

Electroencephalographic (EEG) Biomarkers in Genetic Neurodevelopmental Disorders

Kimberly Goodspeed et al. J Child Neurol. 2023 May.

Abstract

Collectively, neurodevelopmental disorders are highly prevalent, but more than a third of neurodevelopmental disorders have an identifiable genetic etiology, each of which is individually rare. The genes associated with neurodevelopmental disorders are often involved in early brain development, neuronal signaling, or synaptic plasticity. Novel treatments for many genetic neurodevelopmental disorders are being developed, but disease-relevant clinical outcome assessments and biomarkers are limited. Electroencephalography (EEG) is a promising noninvasive potential biomarker of brain function. It has been used extensively in epileptic disorders, but its application in neurodevelopmental disorders needs further investigation. In this review, we explore the use of EEG in 3 of the most prevalent genetic neurodevelopmental disorders-Angelman syndrome, Rett syndrome, and fragile X syndrome. Quantitative analyses of EEGs, such as power spectral analysis or measures of connectivity, can quantify EEG signatures seen on qualitative review and potentially correlate with phenotypes. In both Angelman syndrome and Rett syndrome, increased delta power on spectral analysis has correlated with clinical markers of disease severity including developmental disability and seizure burden, whereas spectral power analysis on EEG in fragile X syndrome tends to demonstrate abnormalities in gamma power. Further studies are needed to establish reliable relationships between quantitative EEG biomarkers and clinical phenotypes in rare genetic neurodevelopmental disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Electroencephalography (EEG) is a powerful tool to evaluate brain state and connectivity. As a clinical tool, EEG is used to evaluate for seizures, epileptiform discharges, and states of consciousness or encephalopathy. Qualitative review of EEG data generates a rich description of the record that can be captured as categorical data; however, quantitative analyses can also be applied to generated continuous data, such as power spectral density or measures of connectivity.

References

    1. Zablotsky B, Black LI, Maenner MJ, et al. Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009–2017. Pediatrics. 2019;144. 2019/09/29. DOI: 10.1542/peds.2019-0811. - DOI - PMC - PubMed
    1. Manickam K, McClain MR, Demmer LA, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:2029‐2037. 2021/07/03. DOI: 10.1038/s41436-021-01242-6. - DOI - PubMed
    1. Waggoner D, Wain KE, Dubuc AM, et al. Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20:1105‐1113. 2018/06/20. DOI: 10.1038/s41436-018-0040-6. - DOI - PMC - PubMed
    1. Satterstrom FK, Kosmicki JA, Wang J, et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell. 2020;180:568–584 e523. 2020/01/26. DOI: 10.1016/j.cell.2019.12.036. - DOI - PMC - PubMed
    1. Loth E, Murphy DG, Spooren W. Defining precision medicine approaches to autism spectrum disorders: concepts and challenges. Front Psychiatry. 2016;7:188. 2016/12/15. DOI: 10.3389/fpsyt.2016.00188. - DOI - PMC - PubMed

Publication types

MeSH terms